J7607 Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg

Short descriptor: Levalbuterol comp con

✓ Active HCPCS Level II 2026
Open J7607 in the app →

Look up J7607 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

J7607 is the HCPCS Level II code for Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2007-01-01
2026 Maintenance
No change this year

Drug Details

Drug / Substance
Levalbuterol, compounded product, administered through dme, concentrated form
Dose / Unit
0.5 mg
Route
inhalation solution

See the full HCPCS Table of Drugs (J-codes).

References

Cite This Page

Reference J7607 with the canonical source and edition:

J7607 — Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J7607

Canonical URL: https://icd10codingpro.com/hcpcs-codes/J7607

Related Codes in Section J

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial